Envoy Medical, Inc.·4

Jun 9, 8:58 PM ET

Lucas Brent T. 4

4 · Envoy Medical, Inc. · Filed Jun 9, 2025

Insider Transaction Report

Form 4
Period: 2024-11-30
Lucas Brent T.
DirectorChief Executive Officer
Transactions
  • Award

    Class A Common Stock

    2025-05-30$1.29/sh+7,742$10,008216,485 total
  • Award

    Class A Common Stock

    2024-11-30$1.94/sh+5,165$10,020208,743 total
Holdings
  • Warrant (right to buy)

    Exercise: $11.50Exp: 2028-09-29Class A Common Stock (16,694 underlying)
    110,987
  • Stock Option (right to buy)

    Exercise: $2.40Exp: 2033-10-15Class A Common Stock (879,749 underlying)
    879,749
  • Warrant (right to buy)

    Exercise: $11.50Exp: 2028-09-29Class A Common Stock (94,293 underlying)
    94,293
Footnotes (3)
  • [F1]These shares were acquired under the Envoy Medical, Inc. Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).
  • [F2]Options to purchase 659,811 shares vest on 10/15/2023, and 219,938 shares vest pro rata on the 15th of each month thereafter for 36 consecutive months.
  • [F3]Fully exercisable.

Documents

1 file
  • 4
    form4.xmlPrimary

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES